Ligne de temps

Nicolas Escriou
Chercheur(euse) Permanent(e)
01 Jan 2022
publication

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.

Lire plus
21 May 2021
publication

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.

Lire plus
01 Jan 2021
publication

High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.

Lire plus
16 Dec 2020
publication

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.

Lire plus
02 Sep 2020
publication

A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

Lire plus
10 Apr 2020
project

CORONABODIES

Lire plus
04 Jul 2015
project

Bivalent vaccines derived from measles vaccine

Lire plus
11 May 2015
team

Génétique Moléculaire des Virus à ARN

Lire plus
11 May 2015
team

Laboratoire d’innovation : vaccins

Lire plus